Kontafarma China Holdings Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	173	145	201	251	274	486
Market Cap Growth	6.90%	-27.78%	-20.00%	-8.16%	-43.68%	-45.63%
Enterprise Value	267	348	429	821	1,067	1,713
Last Close Price	0.03	0.03	0.04	0.04	0.05	0.09
PS Ratio	0.19	0.16	0.25	0.28	0.34	0.48
PB Ratio	0.28	0.15	0.19	0.22	0.21	0.36
P/TBV Ratio	0.41	0.29	0.36	0.47	0.49	0.91
P/FCF Ratio	5.39	4.35	15.25	-	34.77	9.53
P/OCF Ratio	3.49	3.09	5.42	-	3.65	2.35
EV/Sales Ratio	0.30	0.39	0.53	0.92	1.33	1.70
EV/EBITDA Ratio	12.17	-	-	-	-	21.12
EV/EBIT Ratio	-	-	-	-	-	97.68
EV/FCF Ratio	8.30	10.42	32.54	-	135.48	33.58
Debt / Equity Ratio	0.38	0.31	0.31	0.51	0.55	0.58
Debt / EBITDA Ratio	10.77	5.54	22.54	12.76	15.38	4.82
Debt / FCF Ratio	7.34	8.90	25.30	-	92.57	15.34
Net Debt / Equity Ratio	0.25	0.22	0.23	0.39	0.41	0.43
Net Debt / EBITDA Ratio	-3.92	-18.78	-4.94	-14.83	-13.62	7.25
Net Debt / FCF Ratio	4.90	6.18	18.65	-8.32	69.21	11.52
Asset Turnover	0.63	0.54	0.42	0.38	0.32	0.31
Inventory Turnover	4.43	4.14	3.22	3.22	3.51	3.88
Quick Ratio	0.79	1.00	1.18	1.02	0.82	1.00
Current Ratio	1.02	1.26	1.53	1.37	1.11	1.24
Return on Equity (ROE)	-49.46%	-9.79%	-5.51%	-8.80%	-4.18%	-1.23%
Return on Assets (ROA)	-3.31%	-1.71%	-3.00%	-2.25%	-2.39%	0.34%
Return on Invested Capital (ROIC)	-9.66%	-3.65%	-6.34%	-4.84%	-5.11%	0.76%
Return on Capital Employed (ROCE)	-10.20%	-4.00%	-6.90%	-5.20%	-5.30%	0.90%
Earnings Yield	-209.39%	-51.99%	-14.34%	-16.52%	-5.50%	-54.95%
FCF Yield	18.55%	22.99%	6.56%	-21.41%	2.88%	10.50%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.